# NIH Reform Act (S. 664) - Plain Language Summary

## What This Bill Does

This bill would split up the National Institute of Allergy and Infectious Diseases (NIAID) into three separate research institutes within the National Institutes of Health (NIH). Currently, NIAID handles research on allergies, infectious diseases, and immune system disorders all under one director. The bill would create three independent institutes instead: one focused on allergic diseases, one on infectious diseases (including tropical diseases), and one on immunologic diseases. Each new institute would have its own director appointed by the President with Senate approval.

## Who Is Affected

This change would primarily affect:
- **NIH leadership and structure** - The organization would grow from 27 to 29 total institutes
- **Medical researchers** - Scientists studying these three areas would work within separate organizational units with distinct leadership
- **Public health priorities** - The split could change how funding and research focus are distributed among these three related but distinct health areas
- **Patients** - Potentially affecting how research is prioritized and conducted for allergic, infectious, and immune diseases

## Key Changes

- **Three new directors** would be appointed (each serving 5-year terms, renewable once) instead of one NIAID director
- **Organizational separation** - Research areas that were previously coordinated under one institute would now operate independently
- **Transition period** - The NIH Director would oversee all three institutes temporarily until new directors are appointed
- **Scope changes** - The remaining allergic diseases institute would focus only on allergies, while infectious and immune diseases would have their own dedicated institutes